Subsequently, we explored the potential mechanisms of SOX13 in breast carcinogenesis, and we found that silencing SOX13 significantly inhibited glycolysis, whereas overexpressing SOX13 accelerated the glycolysis of breast cancer cells. This evidence concerns the gene SOX13 and breast carcinoma.